Showing results (251-260 of 338) with videos related to

Sort By:
Pageof 34
Journal of Cardiovascular Pharmacology and Therapeutics|August 23, 2018
Angiotensin-Converting Enzyme Inhibitors Provide Better Long-Term Survival Benefits to Patients With AMI Than Angiotensin II Receptor Blockers After Survival Hospital DischargeIn Suck Choi, Ie Byung Park, Kiyoung Lee, et al.
Translational Lung Cancer Research|January 9, 2026
Exon-level TP53 alterations and PD-L1 expression identified by pretreatment NGS stratify survival in EGFR-mutant non-small cell lung cancer treated with first-line osimertinibSeong-Eun Kim, Yongjae Kim, Do Kyung Yoon, et al.
Transfusion|May 21, 2009
Higher infused CD34+ hematopoietic stem cell dose correlates with earlier lymphocyte recovery and better clinical outcome after autologous stem cell transplantation in non-Hodgkin's lymphomaDok Hyun Yoon, Byeong Seok Sohn, Geundoo Jang, et al.
Radiology|February 11, 2005
Dose-volumetric parameters for predicting severe radiation pneumonitis after three-dimensional conformal radiation therapy for lung cancerTae Hyun Kim, Kwan Ho Cho, Hong Ryull Pyo, et al.
JTO Clinical and Research Reports|January 13, 2022
Clinical Characteristics and Outcomes in Advanced KRAS-Mutated NSCLC: A Multicenter Collaboration in Asia (ATORG-005)Jiyun Lee, Aaron C Tan, Siqin Zhou, et al.
Cancer Research and Treatment|October 4, 2021
Integrin αvβ3 Induces HSP90 Inhibitor Resistance via FAK Activation in KRAS-Mutant Non-Small Cell Lung CancerShinkyo Yoon, Hannah Yang, Hyun-Min Ryu, et al.
Lung Cancer (Amsterdam, Netherlands)|February 23, 2016
A multicenter phase II study of sorafenib in combination with erlotinib in patients with advanced non-small cell lung cancer (KCSG-0806)Sun Min Lim, Byoung Chul Cho, Sang-We Kim, et al.
JAMA Network Open|February 9, 2024
Epidemiology and Outcomes of Non-Small Cell Lung Cancer in South KoreaHyun Ae Jung, Dae Ho Lee, Sun Min Lim, et al.
Head & Neck|September 4, 2007
SMART (simultaneous modulated accelerated radiotherapy) for locally advanced nasopharyngeal carcinomasWoong Sub Koom, Tae Hyun Kim, Kyung Hwan Shin, et al.
Lung Cancer (Amsterdam, Netherlands)|October 1, 2013
A randomized, phase II study of vandetanib maintenance for advanced or metastatic non-small-cell lung cancer following first-line platinum-doublet chemotherapyJin Seok Ahn, Ki Hyeong Lee, Jong-Mu Sun, et al.
Pageof 34